Waleczek, F. J. G.
Sansonetti, M.
Xiao, K.
Jung, M.
Mitzka, S.
Dendorfer, A.
Weber, N.
Perbellini, F.
Thum, T. http://orcid.org/0000-0003-4360-1511
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC1470)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 19 January 2022
Revised: 16 November 2022
Accepted: 16 November 2022
First Online: 30 November 2022
Declarations
:
: TT is founder and shareholder of Cardior Pharmaceuticals (outside of this study). TT filed and received royalties from patents about noncoding RNAs (outside of this study). AD is a co-founder and shareholder of InVitroSys GmbH, a company developing specialized tissue culture equipment.